Chesapeake Urology Associates
806 Landmark Drive, Suite 118
Glen Burnie, MD 21061
(410) 760-9400 - Office
(410) 787-1911 - Fax
1989 Diplomate, NBME
1996 Diplomate, American Board Of Urology
2003 Fellow American College of Surgeons
2004 Recertification American Board of Urology
2004 Greenlight Laser Training
2007 Endocare Targeted Cyrosurgical Training
Chief Medical Officer of Chesapeake Urology Associates
1993-2009 Maryland Board of Physician Quality Assurance
EDUCATION:
1984 B.S., University of Maryland, College Park, MD
1988 M.D., University of Maryland, School of Medicine,
College Park, MD
1998 - 1990 General Surgery Residency
Department of Surgery
University of Maryland
Baltimore, Maryland
1990-1994 Urology Residency
Division of Urology
University of Maryland
Baltimore, Maryland
1996 Bard Transurethral Contigen Course
MAJOR RESEARCH INTERESTS:
Erectile Dysfunction
Peyronie's Disease
Transplant Ureteral Reconstruction
Cryosurgery
Endoscopy
Urological Oncology
2008 Chief Medical Officer Chesapeake Urology Associates
2002 - 2006 Chairman of Urology
University of Maryland School of Medicine
2001 Residency Director of Urology
University of Maryland School of Medicine
2000 Associate Professor
Department of Surgery, Division of Urology
University of Maryland, School of Medicine
Baltimore, Maryland
1994 Assistant Professor
Department of Surgery, Division of Urology
University of Maryland
Baltimore, Maryland
1994-2006 Attending Urologist
Veterans Affairs Medical Health Care Systems
Baltimore, Maryland
1994-Present Maryland Kidney Stone Center
Baltimore, Maryland
PROFESSIONAL MEMBERSHIPS:
1988-Present Rush Medical Club
1993-Present American Urological Association
1993-Present Medical Alumni Association
1993-Present Mid-Atlantic AUA
1996-Present Maryland Medical Association
1997-Present Maryland Urological Society
1997-Present Splint Club
1998-Present Society for the Study of Impotence
1998-Present Society of Laparoendoscopic Surgeons
1998-Present University of Maryland Surgical Society
1998-Pesent National Kidney Foundation Medical Advisory Board
2000-Present Society for Basic Urologic Research
2000-Present Sexual Medicine Society of North America
2002-Present Society of Urological Oncology
2002-Present Endourological Society
2005-present American Association of Clinical Urologists
1998-Present National Kidney Foundation Medical Advisory Board
1996-1998 Medical Advisor for the American Paruresis Society
1996-1998 Prostate Cancer Screening AFUD Prostate Cancer
Awareness Week
2000 Baltimore City Outreach Program (Speaker)
2000 Board Member Maryland Urological Society
2001 Mini-Medical School Committee/Speaker
2001 US TOO Prostate Cancer Support Group/Speaker
2001 Getting into Gear New Tactics for Men's Health
2001 Local Arrangements Committee Mid-Atlantic Urologic Meeting
2001 University of Maryland SOM Council Faculty Representative
2002 Representative AUA PGC Erectile Dysfunction Guide Panel
2003-Present Maryland Kidney Stone Center-Quality Assurance Team
2003 Search Committee Surgical Care Clinical Center
Director Baltimore VA Medical Center
2007 BWMC Prostate Cancer Screening
2008 Chesapeake Urology Associates/Man to Man Speaker (Prostate Cancer/ED)
2008 Man To Man Speaker Carrol County Medical Center
2008 BWMC Prostate Cancer Screening
2008 Bethel AME Free Prostate Cancer Screening
2008 AUA-CAP Prostate Biopsy Determination Team Member
8/1/97-6/1/99 A Randomized, Double-Blind Study (With Open-Label
Treatment Extension To Evaluate the Efficacy and
Safety of Viagra (Sildenafil) in Erectile Dysfunction.
Protocol # R-0530; IRB# 0797119 Pfizer: $13,000
11/99 Phase IV Trial of Sildenafil Citrate in patients with
prostate cancer undergoing androgen ablation, Pfizer
support $22,000
11/99 Open Label Dose Escalation Trial of Vasoma Schering-
Pough ~ $12,000
10/00 A dose finding study of Sumanirole in male
moderate to severe erectile dysfunction, a double blind,
placebo controlled, parallel group design with a
4 week home treatment phase
Pharmacia & Upjohn~$15, 000
10/00 Development and Validation of a Male Sexual Distress
Scale
Co-Investigator
Primary Investigator- Leonard R. Derogatis, Ph.D.
10/00 Erectile Dysfunction In the Dual Kidney Transplant
Recipient:National Kidney Foundation of Maryland Clincal
Research Grant $2500.00
01/01 A Nonrandomized, Parallel-group, Multicenter Validation Study
of the Profile of Female Sexual Function and the Sexual
Activity
Log in Naturally and Surgically Menopausal Women with Low
Libido, Compared with a normal libido Control Group
Co-Invesitgator.
Primary investigator Leonard Derogatis Ph.D.
Proctor and Gamble Pharmaceuticals
02/01 A Randomized, Placebo-controlled, Double-Blind, Parallel
Design Study of the Efficacy and Safety of Femprox Cream in
Premenopausal Patients with Female Sexual Arousal
Disorder. NexMed Inc.
06/01 Collaborator NIH grant "Effects of stretch on IC and Normal
Urothelia" Grant # R01-DK59441-01.
Funding Period 06/01/01-05/31/06.
PI: Toby Chai, M.D.
07/01 Long Term Efficacy and Safety of Alfuzosin 10MG OD on the Risk
of Acute Urinary Retention and the Need for Surgery in Patients With
BPH. A Two-year , Randomized, Placebo-controlled Study.
Primary Investigator: Michael Naslund
07/01 A Double-Blind Randomized Parallel Group Study of Alfuzosin 10MG
OD Versus Placebo in the Management of Acute Urinary
Retention in Patients With a First Episode Due to BPH.
Primary Investigator: Michael Naslund
01/02 A Double Blind Placebo-controlled, Parallel Group Design Study
of Two Doses of Lasofoxifene vs. Placebo for the Treatment of Sexual
Dysfunction (Hypoactive Desire) in Postmenopausal Women
01/02 A Double Blind Placebo-controlled, Parallel Group Design Study
of Two Doses of Lasofoxifene vs. Placebo for the Treatment of Sexual
Dysfunction (Arousal Disorder) in Postmenopausal Women
01/02 A Randomized, Placebo-Controlled, Double-Blind, Parallel Design
Phase 3 Trial of the Efficacy and Safety of Alprox TD in Male Patients
With Erectile Dysfunction
07/02 A Phase 3 Multinational, Randomized, Double-Blind, Parallel-group,
Placebo controlled Study to Evaluate the Efficacy and Safety of
Transdermal Testosterone (300mcg/day) for 24 weeks and Safety for a
further 28 Week Open Label Period in Women With Hypoactive
Sexual Desire Disorder on Concurrent Estrogen Replacement Therapy
Who Have Undergone Hysterectomy and Bilateral Oophorectomy
07/04 CAMUS U-01:DK63778-02,
Co-Investigator.
Principal Investigator Michael Naslund, M.D.
07/04 A Case-Control Study Of Prostate Cancer In The Greater Baltimore
Area: An Epidemiological Study of Genetic Risk Factors For Prostate
Cancer In African-American And Caucasian Males
(Associate Investigator)
07/05 A Randomized, Double-Blind, Placebo-Controlled, Multicenter
Efficacy And Safety Study Of Toremifene Citrate For The Prevention
Of Prostate Cancer In Men With High Grade Prostatic
Intraepithelial Neoplasia
(Co-investigator)
07/05 A Randomized, Double-Blind, Placebo-Controlled, Multicenter
Efficacy And Safety Study Of Toremifene Citrate For The Prevention Of
Bone Fractures In Men With Prostate Cancer On Androgen
Deprivation Therapy.
(Co-investigator)
Reviewer for Journal of Urology
Reviewer for Urology
Reviewer for World Journal of Urology
Reviewer for Prostate Cancer and Prostatic Diseases
Reviewer for American Urological Association Meeting Sexual Function Session -1999-2008Editorial Board for International Journal of Impotence Research 2004
Reviewer for Patient Education and Counseling
Reviewer for Asain Journal of Andrology
Reviewer for American Journal of Transplantation
PFIZER-SILDENAFIL CITRATE
SCHERING-PLOUGH- VASOMAX CONSULTANT
BAYER -BAY-38-9456
TRENDS AND PERSPECTIVES IN THE MANAGEMENT OF UTI'S BAYER 3/9/2000
PHARMACIA & UPJOHN
American Kidney Stone Management- Research Ethics Panel
The Councils of Advisors
E-Medicine
Lilly/Icos-Cialis Science Research Advisory board
1994-Present University of Maryland
School of Medicine
Applicant Interviews
1995-Present Medical Chart Review Committee
1995-Present Medical Records Committee
Baltimore Medical VA Medical Center
1996-1997 Technology Management
Committee-UMMS
June 1997 Department of Surgery
Performance Improvement Committee-UMMS
November 1997 National Kidney Foundation
to Present Medical Advisory Board
December 2000 Mini-Medical School Committee
December 2001 Urology Mentor University of Maryland School of Medicine
December 2002 University of Maryland School of Medicine Council
May 2003 University of Maryland Faculty Assembly
January 2004 Surgeons Value Analysis Committee
October 2004 Ambulatory Operations Committee
November 2004 Ambulatory Services Medical Director Council
November 2004 Ambulatory Services Medical Clinic Director- Surgery Clinics
1994-2006 Laboratory Instructor (Freshman Anatomy-Pelvis and Perineum)
1994-2006 Surgery-Junior Student Lectures ( Male Sexual Function)
1994-2006 General Surgery Senior Resident Review Conference (General Urology)
1996 Maryland Kidney Stone Center Genital Oddities (CME Course)
1996 University of Maryland Medical Core Conference
(Urinary Retention)
1997 Endocrinology Update For the Practicing Physician
(Hypogonadism & Impotence: New Therapeutic Modalities)
1998 Reproductive Biology Seminar - Male Sexual Function
1999 General Surgery Junior Resident Review Conference (General Urology)
1994-2006 Urology Grand Rounds Coordinator
1998-2006 Urology Resident Board Review
2003-2006 Surgery Small Group
2004 Mock Oral Boards-General Surgery
2005 Slice Program Lecturer
2005 University of Maryland ICM instructor - Male Sexual Function